<DOC>
	<DOCNO>NCT01934452</DOCNO>
	<brief_summary>This prospective study investigate characteristic mRCC patient time CR comparison mRCC patient non CR treat Sunitinib , order provide answers/ refection lead follow question : Can identify blood specificity time CR v non CR ? Shall distinguish CR sunitinib alone combine CR ( sunitinib local treatment ) , clinical report 2 cohort present similar time recurrence ( ALBIGES , ASCO 2010 ) ? Can identify potential predictive serum biomarkers recurrence ? ( With aim isolate blood biomarker help treatment discontinuation decision ? )</brief_summary>
	<brief_title>Prospective Observational Analysis Of CR With Sunitinib Treatment In mRCC Patients</brief_title>
	<detailed_description>The main objective study describe characteristic mRCC patient CR Sunitinib ( Cases ) compare characteristic mRCC patient non CR ( control ) order identify factor associate occurrence complete remission . The result obtain sample must representative population target study . The appropriate method obtain representative sample probability sample . A sample size N = 40 ( case ) N = 80 ( Controls ) provide power 80 % detection frequency difference case control correspond OR 0.24 parameter frequency 10 % control arm OR 0.30 parameter frequency around 30 % control arm . The significance level set bilateral 5 % . The data analyze use SAS software ( version 9.1 - SAS Institute , North Carolina , United States ) .</detailed_description>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<mesh_term>Sunitinib</mesh_term>
	<criteria>Patients metastatic renal cell carcinoma , histopathologically confirm Treated sunitinib accord Smpc For case : Achieving CR ( local assessment accord RECIST V1.0 criterion ) Sunitinib prior 6 month alone OR combination local treatment ( surgery , radiation therapy , ablative technique : cryotherapy , RFA ) For control : Life expectancy &gt; 3 month No prior Sunitinib treatment Patient &gt; 18 year Sunitinib administer nonapproved label For case : CR occur without sunitinib treatment For control : Prior systemic treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>complete remission</keyword>
</DOC>